 |
|
Human Total Tau Kit
|
| Tau has emerged as a putative therapeutic target for many neurodegenerative disorders. Tau and several hyperphosphorylated forms of this protein are major components of paired helical filaments and other large intracellular aggregates in the brains of patients with Alzheimer's disease and other neurodegenerative disorders such as frontotemporal dementia, Pick’s disease, and related tauopathies. Tau and Aβ42 have been identified as core biomarkers of Alzheimer’s disease. Their levels in cerebrospinal fluid (CSF) reproducibly distinguished normal and Alzheimer’s patients, and in combination, they may be useful in identifying patients with mild cognitive impairment (MCI) or other types of neurodegenerative dementia. The Human Total Tau Kit is a validated assay for the quantitative determination of total tau protein, including its six isoforms (352 to 441 amino acids), in human CSF. |
Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid.
Schipke, C.G., Jessen, F., Teipel, S., Luckhaus, C., Wiltfang, J., Esselmann, H., Frölich, L., Maier, W., Rüther, E., Heppner, F.L., Prokop, S., Heuser, I., Peters, O.
|
J Alzheimers Dis. |
2011 |
|
Identification of SPARC-like Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid.
Vafadar-Isfahani, B., Ball, G., Coveney, C., Lemetre, C., Boocock, D., Minthon, L., Hansson, O., Miles, A.K., Janciauskiene, S.M., Warden, D., Smith, A.D., Wilcock, G., Kalsheker, N., Rees, R., Matharoo-Ball, B., Morgan, K.
|
J Alzheimers Dis. |
2011 |
|
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
Mattsson, N., Andreasson, U., Persson, S., Arai, H., Batish, S.D., Bernardini, S., et al.
|
Alzheimers Dement. |
2011 |
|
Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.
Schipke, C.G., Prokop, S., Heppner, F.L., Heuser, I., Peters, O.
|
Dement Geriatr Cogn Disord. |
2011 |
|
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS.
|
Nature. |
2012 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
1 plate |
| Catalog No. |
K151LAE-1 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K151LAE-1
